Your browser version may not work well with NCBI's Web applications. More information here...
1: J Am Acad Dermatol. 1999 Jul;41(1):1-14; quiz 15-6.Click here to read Links

Varicella zoster virus.

McCrary ML, Severson J, Tyring SK.

Section of Dermatology, Medical College of Georgia, Augusta, USA.

Because of its ability to produce two clinically distinct disease entities (chickenpox and shingles), varicella zoster virus (VZV) is an unusual etiologic agent. Although in the past viral exanthems were mostly only of academic interest to the practitioner, the development of antiviral agents and the newly approved varicella (OKA) vaccine have increased the clinical significance. Also, with the increasing seroprevalence of HIV infection, more patients will be stricken with zoster (at a younger age) and disseminated varicella. In this review, the history, incidence, pathogenesis, clinical manifestations, and treatment options (of VZV infection and postherpetic neuralgia) will be discussed.

PMID: 10411403 [PubMed - indexed for MEDLINE]

Patient Drug Information

  • Varicella (Chickenpox) Vaccine (Varivax® , ProQuad® )

    Chickenpox (also called varicella) is a common childhood disease. It is usually mild, but it can be serious, especially in young infants and adults.

  • Shingles (Zoster) Vaccine (Zostavax® )

    Shingles is a painful skin rash, often with blisters. It is also called Herpes Zoster. A shingles rash usually appears on one side of the face or body and lasts from 2 to 4 weeks. Its main symptom is pain, which can be q...

  • Source: AHFS Consumer Medication Information

Recent Activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on